Information needs persist after genetic counseling and testing for BRCA1/2 and Lynch Syndrome
Breast Cancer Research and Treatment · 2024
DOI: 10.1007/s10549-024-07377-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Breast Cancer Research and Treatment, 2024. Verfasst von Lucy A Peipins und 3 weiteren Autor:innen. Beteiligte Einrichtung: Epidemiology and Applied Research Branch, Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, USA. lb…. Hauptthemen laut MEDLINE: Genetic Counseling, Genetic Testing, Colorectal Neoplasms, Hereditary Nonpolyposis, Genetic Predisposition to Disease. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS.
Abstract (Originalsprache)
PURPOSE: Research has shown that cancer genetic risk is often not well understood by patients undergoing genetic testing and counseling. We describe the barriers to understanding genetic risk and the needs of high-risk persons and cancer survivors who have undergone genetic testing. METHODS: Using data from an internet survey of adults living in the USA who responded 'yes' to having ever had a genetic test to determine cancer risk (N = 696), we conducted bivariate analyses and multivariable logistic regression models to evaluate associations between demographic, clinical, and communication-related variables by our key outcome of having vs. not having enough information about genetics and cancer to speak with family. Percentages for yes and no responses to queries about unmet informational needs were calculated. Patient satisfaction with counseling and percentage disclosure of genetic risk status to family were also calculated. RESULTS: We found that a lack of resources provided by provider to inform family members and a lack of materials provided along with genetic test results were strongly associated with not having enough information about genetics and cancer (OR 4.54 95% CI 2.40-8.59 and OR 2.19 95% CI 1.16-4.14 respectively). Among participants undergoing genetic counseling, almost half reported needing more information on what genetic risk means for them and their family and how genetic testing results might impact future screening. CONCLUSION: High levels of satisfaction with genetic counseling may not give a full picture of the patient-provider interaction and may miss potential unmet needs of the patient. Accessible resources and ongoing opportunities for updating family history information could reinforce knowledge about genetic risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Epidemiology and Applied Research Branch, Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, USA. lbp6@cdc.gov.
- Centers for Disease Control and Prevention, NCCDPHP/DCPC, 4770 Buford Hwy., NE, Mailstop S107-4, Chamblee, GA, USA. lbp6@cdc.gov.
- CyberData Technologies, Inc., Herndon, VA, 20170, USA.
- NORC at the University of Chicago, Chicago, IL, 60603, USA.
- Epidemiology and Applied Research Branch, Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Förderung
- Intramural CDC HHS
Zitieren
APA
Peipins, L. A., Dasari, S., Viox, M. H., & Rodriguez, J. L. (2024). Information needs persist after genetic counseling and testing for BRCA1/2 and Lynch Syndrome. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-024-07377-9
Vancouver
Peipins LA, Dasari S, Viox MH, Rodriguez JL. Information needs persist after genetic counseling and testing for BRCA1/2 and Lynch Syndrome. Breast Cancer Research and Treatment. 2024. doi:10.1007/s10549-024-07377-9
BibTeX
@article{Peipins2024,
author = {Peipins, Lucy A and Dasari, Sabitha and Viox, Melissa Heim and Rodriguez, Juan L},
title = {Information needs persist after genetic counseling and testing for BRCA1/2 and Lynch Syndrome},
journal = {Breast Cancer Research and Treatment},
year = {2024},
doi = {10.1007/s10549-024-07377-9}
}
EUVIMED